The expression of PD-L1 and PD-1 in early breast cancer is associated with higher TIL scores and pCR; conversely, the expression of these proteins is associated with poor prognostic clinicopathological factors such as tumor grade and subtype [16]. This evidence concerns the gene CD274 and breast carcinoma.